Silver Spike Investment Corp (SSIC)

$11.295

+0.13

(+1.12%)

Market is closed - opens 7 PM, 07 May 2024

Insights on Silver Spike Investment Corp

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 1.64M → 3.62M (in $), with an average increase of 30.6% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, 1.21M → 2.49M (in $), with an average increase of 27.0% per quarter

  • Vs NBIX

    In the last 1 year, Neurocrine Biosciences Inc. has given 44.5% return, outperforming this stock by 13.1%

Performance

  • $11.23
    $11.33
    $11.30
    downward going graph

    0.62%

    Downside

    Day's Volatility :0.88%

    Upside

    0.26%

    downward going graph
  • $6.24
    $11.30
    $11.30
    downward going graph

    44.78%

    Downside

    52 Weeks Volatility :44.78%

    Upside

    0.0%

    downward going graph

Returns

PeriodSilver Spike Investment CorpIndex (Russel 2000)
3 Months
39.45%
0.0%
6 Months
20.11%
0.0%
1 Year
29.73%
0.5%
3 Years
-20.21%
-21.1%

Highlights

Market Capitalization
69.0M
Book Value
$13.77
Dividend Share
0.48
Dividend Yield
6.57%
Earnings Per Share (EPS)
-0.54
Wall Street Target Price
11.4
Profit Margin
61.51%
Operating Margin TTM
66.94%
Return On Assets TTM
5.23%
Return On Equity TTM
8.53%
Revenue TTM
11.9M
Revenue Per Share TTM
1.92
Quarterly Revenue Growth YOY
79.0%
Gross Profit TTM
5.4M
Diluted Eps TTM
-0.54
Quarterly Earnings Growth YOY
1.16
EPS Estimate Current Year
0.46
EPS Estimate Next Year
0.99
EPS Estimate Current Quarter
0.27
EPS Estimate Next Quarter
0.18

Analyst Recommendation

Buy
    75%Buy
    25%Hold
    0
    0%Sell
Based on 8 Wall street analysts offering stock ratings for Silver Spike Investment Corp(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
2
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 0.93%

Current $11.30
Target $11.40

Technicals Summary

Sell

Neutral

Buy

Silver Spike Investment Corp is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Silver Spike Investment Corp
Silver Spike Investment Corp
15.15%
20.11%
29.73%
-20.21%
-20.21%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
0.91%
23.42%
43.73%
57.34%
76.99%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
0.97%
2.34%
-6.64%
12.01%
12.01%
Zoetis Inc.
Zoetis Inc.
0.83%
2.39%
-9.63%
-0.27%
61.69%
Viatris Inc.
Viatris Inc.
0.26%
27.9%
19.96%
-15.43%
-27.91%
Catalent, Inc.
Catalent, Inc.
-0.34%
64.82%
59.33%
-46.79%
21.48%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Silver Spike Investment Corp
Silver Spike Investment Corp
NA
NA
NA
0.46
0.09
0.05
0.07
13.77
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
56.26
56.26
0.44
4.78
0.13
0.09
NA
22.61
Haleon Plc Spon Ads
Haleon Plc Spon Ads
30.0
30.0
1.69
0.45
0.07
0.04
0.03
1.8
Zoetis Inc.
Zoetis Inc.
29.76
29.76
2.58
5.79
0.5
0.13
0.01
10.9
Viatris Inc.
Viatris Inc.
229.4
229.4
NA
2.78
0.0
0.03
0.04
17.05
Catalent, Inc.
Catalent, Inc.
211.02
NA
2.06
0.48
-0.3
-0.01
NA
20.41
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Silver Spike Investment Corp
Silver Spike Investment Corp
Buy
$69.0M
-20.21%
NA
61.51%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
Buy
$14.1B
76.99%
56.26
13.23%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
Buy
$38.4B
12.01%
30.0
9.28%
Zoetis Inc.
Zoetis Inc.
Buy
$68.9B
61.69%
29.76
27.43%
Viatris Inc.
Viatris Inc.
Hold
$13.6B
-27.91%
229.4
0.35%
Catalent, Inc.
Catalent, Inc.
Hold
$10.1B
21.48%
211.02
-31.77%

Institutional Holdings

  • Jacobs Asset Management, LLC

    2.94%
  • Penserra Capital Management, LLC

    1.33%
  • Wells Fargo & Co

    0.08%

Company Information

Organization
Silver Spike Investment Corp
Employees
0
CEO
Mr. Scott Charles Gordon
Industry
Miscellaneous

FAQs